Holen Sie sich die Stockscreener-App
6.28
2.94%
-0.19
Handel nachbörslich:
6.29
0.010
+0.16%
Schlusskurs vom Vortag:
$6.47
Offen:
$6.34
24-Stunden-Volumen:
2.95M
Relative Volume:
0.62
Marktkapitalisierung:
$1.14B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-6.5193
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
-3.38%
1M Leistung:
-6.41%
6M Leistung:
+22.42%
1J Leistung:
-17.69%
1-Tages-Spanne:
$6.25
$6.42
1-Wochen-Bereich:
$6.17
$6.61
52-Wochen-Spanne:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.28 | 1.18B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Health (TDOC) Is Down 6.2% After Cutting 2026 Outlook And BetterHelp StrainsHas The Bull Case Changed? - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Bronstein, Gewirtz & Grossman, LLC (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Law firm probes Teladoc Health officers for pos... - Pluang
2026-08-16 | Teladoc Health, Inc. (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:TDOC | Press Release - Stockhouse
5 Best Telemedicine and Telehealth Stocks for 2026 and How to Invest - The Motley Fool
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Healthcare giants team up for new adolescent behavioral care initiative - AOL.com
Truist Securities Adjusts Price Target on Teladoc Health to $8 From $9, Keeps Hold Rating - marketscreener.com
Teladoc Health (TDOC) Institutional Ownership 2026 - MarketBeat
Teladoc Health (TDOC) Could Be 55% Undervalued On Board Change And 2026 Guidance - Sahm
Teladoc's David B. Snow, Jr. to Retire from Board on Sept 30, 2026 - TradingView
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Catapano Joseph Ronald - Moomoo
Teladoc Health (TDOC) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Teladoc Health | 8-K: Current report - moomoo.com
Teladoc Health, Inc. (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.5, Implies 5% Upside - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teladoc Health, Inc. (TDOC) And Encourages Investors to Connect - ACCESS Newswire
Teladoc Health Inc (TDOC) Stock Analysis & Forecast - TradingKey
Teladoc Health Inc (TDOC) Stock News Today - TradingKey
Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript - AOL.com
Teladoc Health, Inc. (TDOC) options chain - Yahoo Finance Australia
Teladoc Health (TDOC) Securities Investigation NoticeLevi & Korsinsky - Morningstar
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation - ACCESS Newswire
Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC - MarketBeat
Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC) - Stock Titan
Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3 - Stock Titan
Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges - DirectorsTalk Interviews
TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC) - Business Wire
Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026 - marketscreener.com
TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Morningstar
Teladoc Health adds former Verisk Analytics exec to board - Investing.com
Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed? - Sahm
Teladoc Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC) - PR Newswire
Teladoc Stock Plummets on Revenue Miss, Lowered Outlook - Schaeffer's Investment Research
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook - TradingView
Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.84, Implies 15% Downside - tradingview.com
Teladoc Health (TDOC) Stock Price Cracks As BetterHelp Reset Deepens - Sahm
Teladoc Health, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Teladoc Lowers BetterHelp Outlook After Cash-Pay Revenue Falls - Stock Titan
Seeking Clues to Teladoc (TDOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Teladoc (TDOC) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teladoc Health Inc-Aktie (TDOC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Catapano Joseph Ronald | Chief Accounting Officer |
Jul 02 '26 |
Sale |
9.10 |
653 |
5,942 |
12,267 |
0.03%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):